The effects of calcitonin on the metabolic disturbances surrounding widespread bony metastases.
D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D001859:Bone Neoplasms / Q000188:drug therapy*; D001943:Breast Neoplasms / Q000628:therapy; D001984:Bronchial Neoplasms / Q000188:drug therapy; D002116:Calcitonin / Q000627:therapeutic use*; D002118:Calcium / Q000097:blood; D002277:Carcinoma / Q000188:drug therapy* / Q000628:therapy; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D005266:Femoral Neoplasms / Q000188:drug therapy; D006801:Humans; D006909:Hydroxyproline / Q000652:urine; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010190:Pancreatic Neoplasms / Q000188:drug therapy; D010386:Pelvic Neoplasms / Q000188:drug therapy; D010710:Phosphates / Q000097:blood / Q000627:therapeutic use; D012272:Ribs; D012540:Scapula; D013125:Spinal Neoplasms / Q000188:drug therapy*
D004967:Estrogens; D010710:Phosphates; D002116:Calcitonin; D000469:Alkaline Phosphatase; D006909:Hydroxyproline; D002118:Calcium